Clinical

Houston Methodist Hospital Investigates Novel Artificial Heart Valve in Low-Risk Aortic Stenosis Patients


By George Kovacik | April 3, 2017

Houston Methodist Hospital is leading the way in the new expanded indication trial for the CoreValve Evolut R System, a minimally invasive treatment for aortic stenosis patients with failing aortic heart valves.

The first two trials focused on patients with an extreme and high surgical risk of mortality. The extreme trial showed that transcatheter aortic valve replacement (TAVR) was better than medical therapy and it was shown to be superior to open heart valve replacement in the high risk trial. The current trial, SurTAVI, found that TAVR was equally as effective as open surgery.

The SurTAVI results recently appeared in the New England Journal of Medicine and were presented at the 2017 American College of Cardiology (ACC) conference by Michael Reardon, M.D., a cardiovascular surgeon at Houston Methodist DeBakey Heart & Vascular Center and the national surgical principal investigator for the SurTAVI trial. Reardon will take on the same role for the new trial looking at low-risk patients.

“The low risk trial includes patients that have a less than 3 percent chance of mortality after open surgery and small chance that they will require an extended stay in the ICU or on a ventilator. This represents about 75 percent of patients. The standard treatment in such patients is open heart surgery to replace the valve,” Reardon said.

Aortic stenosis is a common heart problem caused by narrowing of the heart’s aortic valve due to excessive calcium deposited on the valve leaflets.

“When the valve narrows, it does not open properly, making the heart work harder to pump blood throughout the body,” said Neal Kleiman, M.D., an interventional cardiologist and the low-risk trial principal investigator for Houston Methodist Hospital. “Eventually, this causes the heart to weaken and function poorly, which may lead to heart failure and ultimately death.”

The CoreValve Evolut R System replaces a diseased aortic heart valve through a minimally invasive procedure, without surgical removal of the diseased valve. The device is typically inserted via an artery in the leg and then guided through the arteries into the heart. Once in place, the device expands and takes over the original valve’s function to enable oxygen-rich blood to flow efficiently out of the heart. The system also provides physicians with the option to recapture the valve and reposition it during the procedure as necessary.

The trial will recruit more than 1,200 low-risk patients from up to 80 clinical sites in the United States. It is designed as an adaptive trial with a primary endpoint of all-cause mortality or disabling stroke.

“All the patients in the trial are reviewed by a national committee and then they are randomly selected by a computer program to receive either this procedure or an open surgical aortic valve replacement,” Kleiman said. “One of the benefits for patients is that regardless of which treatment they receive, they are very closely monitored throughout the process. Their cases are reviewed by at least five experts.”

“The success of the previous trials has given a new lease on life to patients who otherwise would not have limited options to treat their aortic stenosis,” Reardon said. “We believe TAVR will be as effective in this group of low-risk patients as it was in the high and intermediate risk patients.”

The CoreValve Evolut R transcatheter valve and the CoreValve EnVeo R Delivery Catheter System were FDA-approved for commercial use in the United States in June 2015 for severe aortic stenosis patients who are at high or extreme risk for surgery.

For more information, or to enroll in this study, please call Houston Methodist Hospital at 713.441.3250.




Social Posts

profile_image

MD Anderson Cancer Center

@MDAndersonNews

RT @KirstiClifford: Rounding with @ppisters and @CarolPorterDNP was extra special today as we recognized our amazing staff @MDAndersonNews…

17 mins ago
profile_image

BCMHouston

@bcmhouston

RT @BCMSpaceHealth: Attention all researchers & scientists. Join Stephen Mayo and TRISH research #spacehealth.Information can be found he…

24 mins ago
profile_image

UTHealth

@UTHealth

RT @UTPhysicians: Dr. Stuart Harlin will be a guest on KPRC TV Channel 2’s Houston Life. At 1:30 today, he will be discussing varicose and…

26 mins ago
profile_image

Harris Health System

@harrishealth

Reduce your risk of cancer - RE: @WHO https://t.co/DGDoZCOXj5

29 mins ago
profile_image

UTMB Health

@utmbhealth

RT @ppisters: I enjoyed my visit yesterday with @utmbhealth president Dr. David Callender and his team. Great tour and time spent learning…

33 mins ago
profile_image

MD Anderson Cancer Center

@MDAndersonNews

Eye cancer survivor Tina Ladowski: "Suddenly, there was hope where none had been before." https://t.co/3cEQhyBpit #Rarecancer @MDAProtons #endcancer https://t.co/7tfmqvlqsB

45 mins ago
profile_image

Veterans Affairs

@DeptVetAffairs

Colorado’s new Rocky Mountain Regional VA Medical Center is open for business https://t.co/btQdn6UuSi via #VAntagePoint

50 mins ago
profile_image

University of Houston

@UHouston

Two University of Houston students and a faculty member, striving to set examples for future generations of women. #GoCoogs! https://t.co/xZWa98q6aW

52 mins ago
profile_image

University of Houston

@UHouston

RT @uhparking: Did you know? Our team has been working hard to get parking permits ready and sent out, so be sure to keep an eye out for yo…

54 mins ago
profile_image

Rice University

@RiceUniversity

RT @RiceUNews: #Houston and #HarrisCounty's serious flooding problems can be solved if funding is available and both the public and local o…

1 hour ago
profile_image

Rice University

@RiceUniversity

Rice’s Disability Support Services has changed its name to the Rice Disability Resource Center to reflect its expanded scope of services offered: https://t.co/63eC9pJn8d https://t.co/UVQXuqI5Qx

1 hour ago
profile_image

BCMHouston

@bcmhouston

Learn how Graduate School of Biomedical Sciences student Jamie Reyes decided to get into research after his grandfather's death. https://t.co/qtE4duuobR #students

1 hour ago
profile_image

BCMHouston

@bcmhouston

Family members and guests joined first-year medical students at Baylor College of Medicine's Family Day on Aug. 11, 2018. The event included campus tours and faculty presentations. View more photos on our Facebook page. https://t.co/PZD1zqjBXL https://t.co/97fj6gZkI2

2 hours ago
profile_image

UTMB Health

@utmbhealth

RT @utmbnews: See the @noticiashouston segment with our own Dr. Cortiella speaking about bioengineering lungs: Investigadores de Texas adel…

2 hours ago
profile_image

Veterans Affairs

@DeptVetAffairs

Tom, a @USArmy Veteran, reconnected with some of his battle buddies years after their service. He finds relief in the camaraderie of being around Veterans who experienced challenges like his own. Hear his story: https://t.co/JERUKq7VeA https://t.co/AW42GALdGO

2 hours ago